Outcomes by MIC Values for Patients Treated with Isavuconazole or Voriconazole for Invasive Aspergillosis in the Phase 3 SECURE and VITAL Trials

This pooled analysis evaluated the relationship of isavuconazole and voriconazole MICs of Aspergillus pathogens at baseline with all-cause mortality and clinical outcomes following treatment with either drug in the SECURE and VITAL trials. Isavuconazole and voriconazole may have had reduced efficacy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Antimicrob Agents Chemother
Main Authors: Andes, David R., Ghannoum, Mahmoud A., Mukherjee, Pranab K., Kovanda, Laura L., Lu, Qiaoyang, Jones, Mark E., Santerre Henriksen, Anne, Lademacher, Christopher, Hope, William W.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2018
Assuntos:
Susceptibility
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325202/
https://ncbi.nlm.nih.gov/pubmed/30373791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01634-18
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados